Suchergebnisse - "Minegishi, Yuji"

PubPharm (109)

1

Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Tozuka, T. | Noro, R. | Mizutani, H. | +15

2

Clinicopathological characteristics of everolimus-associated interstitial lung disease : A single-center consecutive analysis

enthalten in: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi | 2024

von Saito, Y. | Terasaki, Y. | Kashiwada, T. | +11

3

Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer : a retrospective study

enthalten in: Journal of cancer research and clinical oncology | 2023

von Naito, T. | Minegishi, Y. | Shiraishi, H. | +6

4

Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias : A feasibility study

enthalten in: Respiratory investigation | 2023

von Omori, M. | Minegishi, Y. | Uruga, H. | +11

5

Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer: a retrospective study

enthalten in: Journal of cancer research and clinical oncology | 2023

von Naito, T. | Minegishi, Y. | Shiraishi, H. | +6

6

Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer: a retrospective study

enthalten in: Journal of cancer research and clinical oncology | 2023

von Naito, T. | Minegishi, Y. | Shiraishi, H. | +6

7

Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer: a retrospective study

enthalten in: Journal of cancer research and clinical oncology | 2023

von Naito, T. | Minegishi, Y. | Shiraishi, H. | +6

8

Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer : A randomized phase II trial (JMTO LC14-01)

enthalten in: Cancer medicine | 2023

von Takeuchi, S. | Kubota, K. | Sugawara, S. | +15

9

Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias : A retrospective multi-centre cohort study

enthalten in: Respiratory investigation | 2023

von Miyamoto, A. | Michimae, H. | Nakahara, Y. | +10

10

Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer : A randomized phase II trial ( JMTO LC14‐01)

enthalten in: Cancer Medicine | 2023

von Takeuchi, S. | Kubota, K. | Sugawara, S. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]